FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA OKs Delayed-release Nexium Suspension

[ Price : $8.95]

FDA approves a new delayed-release oral suspension formulation for AstraZenecas proton pump inhibitor Nexium.

Latest FDA Warning Letters

[ Price : $8.95]

In its latest batch of Warning Letters FDA cites BioMarin Pharmaceutical, International Brachytherapy, Mallinckrodt and NeuroScien...

More Counterfeit Test Strips Identified

[ Price : $8.95]

FDA releases additional lot numbers and identifying characteristics of counterfeit LifeScan blood glucose test strips.

Novartis Recalling Some Flu Vaccine

[ Price : $8.95]

FDA says Novartis is recalling two lots of Chiron flu vaccine received from Cardinal Health Care that were either frozen or shippe...

Harmonization Task Force Documents Out on Device Regs

[ Price : $8.95]

Federal Register Notice: FDA announces availability of documents from the Global Harmonization Task Force that may be used by gove...

Draft Guidance Out on Portable Glucose Monitors

[ Price : $8.95]

Federal Register Notice: FDA releases a draft guidance on total product life cycle for portable invasive blood glucose monitoring ...

Waxman Continues Push for Phenylephrine Study

[ Price : $8.95]

Rep. Henry Waxman again asks FDA to study phenylephrines effectiveness as an oral decongestant.

NeuroScience Warned On Unapproved New Drugs

[ Price : $8.95]

FDA warns NeuroScience, Inc., it is distributing unapproved new drugs that also are misbranded.

Miami Man Sentenced Over Counterfeit Drugs

[ Price : $8.95]

A federal judge sentences Julio Cesar Cruz to over 13 years in prison for his role in a multi-million dollar counterfeit drug dist...

OMB OKs Info on Emergency Use Authorization

[ Price : $8.95]

Federal Register Notice: The Office of Management and Budget approves FDAs collection of information on emergency use authorizatio...